$4.12 Billion is the total value of Artal Group S.A.'s 137 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 26.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BNTX | Sell | BIONTECH SEsponsored ads | $119,852,000 | -10.2% | 1,731,214 | -13.4% | 2.91% | -22.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $116,480,000 | -12.6% | 800,000 | -11.1% | 2.83% | -24.2% |
| JPM | Sell | JPMORGAN CHASE & COcall | $96,270,000 | -65.9% | 1,000,000 | -66.7% | 2.34% | -70.4% |
| ARGX | Sell | ARGENX SEsponsored adr | $85,109,000 | -16.0% | 324,200 | -28.0% | 2.07% | -27.2% |
| GDS | Sell | GDS HLDGS LTDsponsored ads | $81,830,000 | -6.6% | 1,000,000 | -9.1% | 1.99% | -19.0% |
| FATE | Sell | FATE THERAPEUTICS INC | $59,955,000 | -2.9% | 1,500,000 | -16.7% | 1.46% | -15.8% |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $45,995,000 | -29.5% | 1,521,517 | -1.6% | 1.12% | -38.8% |
| MORF | Sell | MORPHIC HLDG INC | $45,157,000 | +0.0% | 1,651,686 | -1.0% | 1.10% | -13.2% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $44,139,000 | -4.0% | 2,495,140 | -1.1% | 1.07% | -16.6% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $42,360,000 | -19.7% | 3,000,000 | -14.3% | 1.03% | -30.4% |
| TGTX | Sell | TG THERAPEUTICS INC | $40,140,000 | +17.7% | 1,500,000 | -14.3% | 0.97% | +2.1% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $30,780,000 | -20.7% | 600,000 | -7.7% | 0.75% | -31.2% |
| GOSS | Sell | GOSSAMER BIO INC | $29,275,000 | -15.3% | 2,358,968 | -11.3% | 0.71% | -26.5% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $29,160,000 | -19.9% | 2,250,000 | -10.0% | 0.71% | -30.5% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $28,392,000 | +25.6% | 325,000 | -7.1% | 0.69% | +8.8% |
| QURE | Sell | UNIQURE NV | $27,623,000 | -38.7% | 750,000 | -25.0% | 0.67% | -46.8% |
| C | Sell | CITIGROUP INCcall | $21,555,000 | -57.8% | 500,000 | -50.0% | 0.52% | -63.4% |
| MRNA | Sell | MODERNA INC | $21,225,000 | -33.9% | 300,000 | -40.0% | 0.52% | -42.7% |
| Z | Sell | ZILLOW GROUP INCcl c cap stk | $20,318,000 | -27.0% | 200,000 | -58.6% | 0.49% | -36.7% |
| TBIO | Sell | TRANSLATE BIO INC | $19,054,000 | -33.5% | 1,400,000 | -12.5% | 0.46% | -42.3% |
| RUBY | Sell | RUBIUS THERAPEUTICS INC | $18,932,000 | -17.8% | 3,778,913 | -1.9% | 0.46% | -28.7% |
| TCOM | Sell | TRIP COM GROUP LTDads | $17,750,000 | +14.1% | 570,000 | -5.0% | 0.43% | -0.9% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $17,539,000 | -5.8% | 570,000 | -5.0% | 0.43% | -18.2% |
| KURA | Sell | KURA ONCOLOGY INC | $16,824,000 | +78.6% | 549,100 | -5.0% | 0.41% | +54.5% |
| REPL | Sell | REPLIMUNE GROUP INC | $16,114,000 | -13.5% | 700,000 | -6.7% | 0.39% | -25.0% |
| FGEN | Sell | FIBROGEN INC | $15,626,000 | -3.6% | 380,000 | -5.0% | 0.38% | -16.5% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $15,008,000 | -23.3% | 400,000 | -33.3% | 0.36% | -33.5% |
| TECH | Sell | BIO-TECHNE CORP | $14,864,000 | -13.4% | 60,000 | -7.7% | 0.36% | -24.8% |
| DNLI | Sell | DENALI THERAPEUTICS INC | $14,332,000 | +31.7% | 400,000 | -11.1% | 0.35% | +14.5% |
| HARP | Sell | HARPOON THERAPEUTICS INC | $13,592,000 | -9.0% | 800,000 | -11.1% | 0.33% | -21.1% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $13,587,000 | +39.6% | 222,300 | -5.0% | 0.33% | +21.3% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $13,586,000 | +7.8% | 285,000 | -5.0% | 0.33% | -6.5% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $13,168,000 | -4.1% | 400,000 | -20.0% | 0.32% | -16.7% |
| EPZM | Sell | EPIZYME INC | $11,930,000 | -60.4% | 1,000,000 | -46.7% | 0.29% | -65.6% |
| CYCN | Sell | CYCLERION THERAPEUTICS INC | $11,051,000 | +1.5% | 1,817,584 | -1.3% | 0.27% | -11.8% |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $10,942,000 | -15.6% | 285,028 | -5.0% | 0.27% | -26.7% |
| RPRX | Sell | ROYALTY PHARMA PLC | $10,518,000 | -71.1% | 250,000 | -66.7% | 0.26% | -75.0% |
| STOK | Sell | STOKE THERAPEUTICS INC | $9,067,000 | +33.5% | 270,750 | -5.0% | 0.22% | +15.8% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $7,409,000 | -27.2% | 1,045,000 | -5.0% | 0.18% | -36.8% |
| BRKR | Sell | BRUKER CORP | $6,967,000 | -7.2% | 175,275 | -5.0% | 0.17% | -19.5% |
| ARAV | Sell | ARAVIVE INC | $6,163,000 | -61.6% | 1,311,291 | -5.0% | 0.15% | -66.7% |
| RGNX | Sell | REGENXBIO INC | $6,118,000 | -29.0% | 222,300 | -5.0% | 0.15% | -38.2% |
| PRQR | Sell | PROQR THRAPEUTICS N V | $5,730,000 | -25.2% | 1,196,218 | -5.0% | 0.14% | -35.0% |
| LPTX | Sell | LEAP THERAPEUTICS INC | $5,594,000 | -10.0% | 2,825,300 | -5.0% | 0.14% | -21.8% |
| APTX | Sell | APTINYX INC | $5,077,000 | -23.0% | 1,502,035 | -5.0% | 0.12% | -33.2% |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $4,863,000 | -46.5% | 100,000 | -46.8% | 0.12% | -53.5% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $4,557,000 | -48.7% | 427,500 | -27.1% | 0.11% | -55.4% |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $4,115,000 | -21.2% | 465,500 | -5.0% | 0.10% | -31.5% |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $4,011,000 | -18.9% | 142,500 | -18.6% | 0.10% | -29.7% |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $3,777,000 | -24.8% | 190,000 | -20.5% | 0.09% | -34.8% |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $3,564,000 | -29.6% | 142,500 | -5.0% | 0.09% | -38.7% |
| PRTA | Sell | PROTHENA CORP PLC | $3,511,000 | -9.3% | 351,500 | -5.0% | 0.08% | -21.3% |
| SLDB | Sell | SOLID BIOSCIENCES INC | $3,471,000 | -34.2% | 1,710,000 | -5.0% | 0.08% | -43.2% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCsponsored ads | $3,317,000 | -48.3% | 285,000 | -28.8% | 0.08% | -54.7% |
| AXLA | Sell | AXCELLA HEALTH INC | $3,292,000 | -33.9% | 712,500 | -20.8% | 0.08% | -42.4% |
| ADCT | Sell | ADC THERAPEUTICS SA | $3,134,000 | -50.8% | 95,000 | -30.1% | 0.08% | -57.3% |
| PRVL | Sell | PREVAIL THERAPEUTICS INC | $3,082,000 | -44.1% | 302,750 | -18.2% | 0.08% | -51.3% |
| MRUS | Sell | MERUS N V | $3,000,000 | -51.4% | 250,000 | -34.9% | 0.07% | -57.8% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $2,857,000 | -35.3% | 87,400 | -5.0% | 0.07% | -44.4% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $2,600,000 | +5.2% | 133,000 | -5.0% | 0.06% | -8.7% |
| EVLO | Sell | EVELO BIOSCIENCES INC | $2,503,000 | -23.4% | 475,000 | -28.7% | 0.06% | -33.0% |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $2,417,000 | -16.3% | 760,000 | -5.0% | 0.06% | -27.2% |
| ADRO | Sell | ADURO BIOTECH INC | $2,193,000 | -0.1% | 902,500 | -5.0% | 0.05% | -13.1% |
| CRIS | Sell | CURIS INC | $1,644,000 | -8.1% | 1,404,729 | -5.0% | 0.04% | -20.0% |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $1,445,000 | -34.9% | 351,500 | -5.0% | 0.04% | -43.5% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $1,188,000 | -24.1% | 178,600 | -5.0% | 0.03% | -34.1% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $771,000 | +24.6% | 321,100 | -5.0% | 0.02% | +11.8% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $640,000 | -26.7% | 224,675 | -5.0% | 0.02% | -33.3% |
| PASG | Sell | PASSAGE BIO INC | $205,000 | -96.8% | 15,648 | -93.3% | 0.01% | -97.2% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $0 | -100.0% | 8 | -100.0% | 0.00% | -100.0% |
| TORC | Exit | RESTORBIO INC | $0 | – | -953,000 | -100.0% | -0.06% | – |
| CYRX | Exit | CRYOPORT INC | $0 | – | -89,000 | -100.0% | -0.08% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -500,000 | -100.0% | -0.09% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -450,000 | -100.0% | -0.10% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -200,000 | -100.0% | -0.14% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -239,000 | -100.0% | -0.16% | – |
| TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDcall | $0 | – | -100,000 | -100.0% | -0.16% | – |
| HTHT | Exit | HUAZHU GROUP LTDsponsored ads | $0 | – | -175,000 | -100.0% | -0.17% | – |
| MLCO | Exit | MELCO RESORTS AND ENTMNT LTDcall | $0 | – | -500,000 | -100.0% | -0.22% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -574,000 | -100.0% | -0.22% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -285,000 | -100.0% | -0.22% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -230,838 | -100.0% | -0.23% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -65,000 | -100.0% | -0.27% | – |
| BNTX | Exit | BIONTECH SEcall | $0 | – | -150,000 | -100.0% | -0.28% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -200,000 | -100.0% | -0.34% | – |
| VNET | Exit | 21VIANET GROUP INCsponsored ads | $0 | – | -583,000 | -100.0% | -0.39% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.41% | – |
| EPZM | Exit | EPIZYME INCcall | $0 | – | -1,000,000 | -100.0% | -0.45% | – |
| AAL | Exit | AMERICAN AIRLS GROUP INC | $0 | – | -1,500,000 | -100.0% | -0.55% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -376,000 | -100.0% | -0.56% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -2,000,000 | -100.0% | -0.95% | – |
| PYPL | Exit | PAYPAL HLDGS INC | $0 | – | -200,000 | -100.0% | -0.98% | – |
| DAL | Exit | DELTA AIR LINES INC DELcall | $0 | – | -1,250,000 | -100.0% | -0.98% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -550,000 | -100.0% | -1.20% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -500,000 | -100.0% | -1.57% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.